{"entity":{"id":4225,"slug":"patrick-vallance","name":"Patrick Vallance","type":"person","role":"UK Science Minister addressing Palantir contracts","description":null,"imageUrl":null,"createdAt":"2026-04-13T03:10:02.119Z","updatedAt":"2026-04-13T03:10:02.119Z"},"electedOffice":null,"significance":{"score":4.4,"components":{"totalFindings":0,"connectionDegree":2.4,"recentFindings90d":0,"activeResearchJobs":0,"goblinAttributions":2,"recentSyntheses90d":0,"moneyFlowChainsTotal":0,"closedLoopMemberships":0,"moneyFlowHopsRecent90d":0},"computedAt":"2026-10-16T01:34:31.424Z"},"facts":[{"id":18642,"text":"Patrick Vallance filed filing with the SEC on 2017-02-03. Accession number: N/A.","confidence":"secondary","dateOccurred":"2017-02-03","source":{"title":"SEC EDGAR: filing — Patrick Vallance (2017-02-03)","url":"https://efts.sec.gov/LATEST/search-index?q=%22Patrick%20Vallance%22&dateRange=custom&forms=4,SC%2013D,SC%2013G,DEF%2014A,10-K,10-Q","publication":"SEC EDGAR"}},{"id":18646,"text":"Search scope note: No fec donations found for \"Patrick Vallance\" in automated database search as of 2026-04-13. This reflects search coverage limits, not confirmed absence from public record.","confidence":"secondary","dateOccurred":null,"source":null}],"connections":[{"id":15231,"relationshipType":"oversight","description":"Vallance was involved in government health data strategy, which included oversight considerations for NHS England's Federated Data Platform, a system using Palantir's technology.","confidence":"inferential","firstDocumented":"2021","lastDocumented":null,"other":{"id":4227,"name":"Federated Data Platform (FDP)","slug":"federated-data-platform-fdp","type":"instrument"}},{"id":15229,"relationshipType":"oversight","description":"During his tenure as Chief Scientific Adviser, Vallance oversaw scientific aspects of NHS data initiatives, including digital health records and data platforms linked to NHS Digital.","confidence":"inferential","firstDocumented":"2019","lastDocumented":null,"other":{"id":4196,"name":"NHS Digital","slug":"nhs-digital","type":"institution"}},{"id":15232,"relationshipType":"former professional role","description":"Before becoming Chief Scientific Adviser, Vallance was President of Research and Development at Merck KGaA (the German pharmaceutical company), where he worked from 2012 to 2017.","confidence":"primary","firstDocumented":"2012","lastDocumented":null,"other":{"id":442,"name":"Merck KGaA","slug":"merck-kgaa","type":"company"}},{"id":15230,"relationshipType":"former advisory role","description":"As Government Chief Scientific Adviser, Vallance provided scientific advice to the Ministry of Defence on national security and defense technology matters.","confidence":"secondary","firstDocumented":"2018","lastDocumented":null,"other":{"id":90,"name":"UK Ministry of Defence","slug":"uk-ministry-of-defence","type":"institution"}},{"id":15228,"relationshipType":"former advisory role","description":"As the UK Government Chief Scientific Adviser (2018-2023), Vallance worked closely with NHS England on health policy and scientific strategy, including during the pandemic response.","confidence":"secondary","firstDocumented":"2018","lastDocumented":null,"other":{"id":88,"name":"NHS England","slug":"nhs-england","type":"institution"}},{"id":15227,"relationshipType":"former employment/role","description":"Patrick Vallance served as the UK Government Chief Scientific Adviser, which involved advising the Home Office on scientific matters, particularly during the COVID-19 pandemic and border policy issues.","confidence":"secondary","firstDocumented":"2018","lastDocumented":null,"other":{"id":87,"name":"UK Home Office","slug":"uk-home-office","type":"institution"}}],"contradictions":[],"permalink":"https://www.goblinhouse.net/entity/patrick-vallance","timelineUrl":"https://www.goblinhouse.net/entity/patrick-vallance/timeline"}